Last reviewed · How we verify
NCT03366636
Project Legacy Impact Evaluation Study
NA trial testing Project Legacy in Pregnancy Prevention in 571 participants. Completed in 30 March 2021.
30 March 2021
Quick facts
| Lead sponsor | Children's Hospital Los Angeles |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 571 |
| Start date | 30 October 2017 |
| Primary completion | 30 March 2021 |
| Estimated completion | 30 March 2021 |
| Sites | 12 locations across United States |
Drugs / interventions tested
- Project Legacy
Conditions studied
- Pregnancy Prevention — all drugs for Pregnancy Prevention →
- Sexual Behavior — all drugs for Sexual Behavior →
- Contraception Behavior — all drugs for Contraception Behavior →
- Sexually Transmitted Diseases — all drugs for Sexually Transmitted Diseases →
Sponsor
Children's Hospital Los Angeles
Who can join
Adults 14 to 19, any sex, with Pregnancy Prevention or Sexual Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will design and rigorously evaluate the efficacy of Project Legacy, a five week positive youth development intervention to decrease sexual risk for unintended pregnancies and STIs among youth experiencing homelessness or at risk of homelessness aged 14-19. This randomized control trial will compare Project Legacy to a usual services control.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03366636
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pregnancy Prevention
Currently open trials in the same condition.
- NCT06306131 — Phase II Study of Ovulation in Obese Women · Phase 2 · recruiting
- NCT05695352 — Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days · Phase 2 · recruiting
Other Children's Hospital Los Angeles trials
Trials by the same sponsor.
- NCT07064824 — Adaptive Cell Phone Support (ACPS) · NA · not yet recruiting
- NCT07508436 — Crisis Interventions for Pediatric Providers - Autism Version · NA · not yet recruiting
- NCT06934655 — Early Re-Initiation of Semaglutide Post Sleeve Gastrectomy in Youth · Phase 3 · not yet recruiting
- NCT07427862 — Virtual Reality (VR) for Interventional Radiology (IR) Procedures · recruiting
- NCT07213908 — Comparing Two School-Based Sleep Health Interventions To Promote Sleep Quality in Youth · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03366636 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Children's Hospital Los Angeles
- Last refreshed: 3 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03366636.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing